The Cannabis Conversation Podcast

This week’s show is a very special one for us - we’re celebrating our 100th episode! In this show, we flip the script with one of our early guests - Thomas Gray from Lumino (formerly Blume Jobs) - interviewing Anuj. In this special episode Anuj reflects on what he's learnt over the last 100 episodes, how things are shaping up in the cannabis industry, and how he's looking to help people...

On this week’s show we’re joined by Narbé Alexandrian, President and CEO at Canopy Rivers - Canadian venture capitalist firm specialising in Cannabis. In our latest episode we explore how Canopy Rivers’ potential investments are evaluated, the globalisation of cannabis, and how important it is for companies to adapt and pivot around regulatory reform. → View full show notes and summary here: https...

On this week’s show we’re joined by Dean Harris, founder of TabBrands, cannabis based health and wellness company who have patented a novel cannabinoid delivery system. This week, we explore the company’s new water soluble cannabinoid technology, including its benefits, unique value proposition, applications across the food and beverage industries, and its potential to truly disrupt the industry....

On this week’s show we’re joined by Matt Hawkins, Managing Partner and Founder of Entourage Effect Capital, US based VC fund focused on the cannabis industry. Join us this week, as we take a look at how VC funds operate, including how they are funded and the types of investments they make, alongside what the recent election means for the future of Cannabis businesses in the USA. → View full show n...

On this week’s show we’re joined by Sean McLintock, CEO and Founder of DrinkThreeDots - CBD beverage startup based in the UK. In our latest episode, we explore the challenges faced bringing a CBD beverage product to market, including formulation, manufacturing, production and marketing, alongside the hot topic of sustainability in the FMCG industry. → View full show notes and summary here: https:/...

On this week’s show we’re joined with Dr Bonni Goldstein, Medical Director of Canna-Centers Wellness and Education - California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions. Bonni is also the author of ‘ Cannabis Is Medicine ’. In this episode, we discuss the role of medical cannabis in paediatric care, exploring its appl...

On this week’s show we’re joined by Gavin Sathianathan & Neil Mahapatra from Oxford Cannabinoid Technologies (OCT) - UK biopharmaceutical company focused on cannabinoid drug development and world class scientific research. We explore the pharmaceutical drug development process, including how clinical trials work, the capital required to make one a success, and how big pharma fit into the value...

On this week’s show we’re joined by Kenzi Riboulet-Zemouli, drug policy advocate, leading researcher, president of FAAAT, and advisory board member of the European Industrial Hemp Association. Kenzi gives us a high-level overview of international drug control, including the treaties and conventions which manage it, and the politics involved. We also take a look at the recent historic removal of Ca...

 On this week’s show we’re joined by Hilary Black, Chief Advocacy Officer at Canopy Growth - world-leading diversified cannabis and hemp company. We look into the complexities of Environmental, Social, and Corporate Governance within the cannabis space - including why ESG is a growing area of importance, and what industry giants, Canopy Growth, are doing to tackle this issue. → View full show note...

On this week’s show we’re joined by Alex Ouimet-Storrs and Bruce Linton of Óskare Capital -  European VC fund focusing on cannabinoid technology, science, and infrastructure investments.  Join us as we explore the role of a VC fund within the cannabis industry, how they operate, and why Europe is currently the most exciting investment space worldwide.  → View full show notes and summary here: http...

On today’s show we’re joined by the incredibly brave Michelle Kendall - advocate, medical cannabis patient and creator of documentary 'Schedule 1'.  Michelle shares with us her incredible personal journey of using medical cannabis to manage ovarian cancer, including how a protocol of high dose THC shrunk the size of her tumour, kept her cancer in remission, and helped her manage symptoms...

On today’s show we’re joined by Dr. Markus Roggen CEO of Complex Biotech Discovery Ventures (CBDVL) - licensed cannabis research and development firm focusing on cannabis extraction optimisation, analytical testing, and chemical process development. Join us as we dive into the chemistry of cannabis, including the different ways in which cannabinoids can be extracted, why the ‘entourage effect’ nee...

On today’s show we’re joined by Angus Taylor, CEO of Infused Products International - pharmaceutical cannabinoid ingredient company based in Canada.  Join us as we take a look at the company's brand new CBD vape pens including how they have been designed and formulated for specific ailments. Angus also gives us his predictions for the future of cannabinoid health within a wider nutraceutical...

How important is personalisation in cannabis medicine? This week we’re joined by Len May, CEO of Endocanna Health - biotechnology research company working with personalised cannabinoid therapeutics. Join us as we explore the purpose of cannabis sequencing, how medical cannabis personalisation is possible, and the benefits that it can offer a consumer. EndoDNA are offering an exclusive discount of...

This week we’re joined by Alexej Pikovsky CEO and Co-Founder of Alphagreen - online marketplace for CBD and alternative health products. Join us as we investigate some of the many marketing challenges CBD brands face when selling online, alongside Alphagreen’s tried and tested SEO strategy and advice on how to gain traction online. → View full show notes and summary here: https://www.canverse.glob...

This week we’re joined by Montel Williams - former TV talk show host, motivational speaker, medical cannabis advocate, and founder of Lenitiv Scientific. Join us as we take a look into Montel’s experience as a medical cannabis patient, his journey as a cannabis entrepreneur, and his predictions for the future of cannabis in the USA. → View full show notes and summary here: https://www.canverse.glo...

This week we’re joined by Peter Vogel, CEO of Leafwire - the world’s latest cannabis and hemp business network and online platform, dubbed ‘the LinkedIn of cannabis’. Join us as we take a look into Leafwire’s unique value proposition, features, and plans for the future. Peter also shares his observations on how Covid-19 has impacted the cannabis industry, and what's trending on the Leafwire p...

This week we’re joined by Aras Azadian, CEO of Avicanna - Canadian bio-pharmaceutical company focused on the research, development and commercialisation of plant-derived cannabinoid-based products.  Join us as we take a look into Avicanna’s business operations, including their vertical integration strategy,  research and development processes, and their newest product developments.  → View full sh...

How important is patient data to show the efficacy of medical cannabis? This week we’re joined by Prof. David Nutt and David Badcock - from Drug Science - the UK’s leading independent scientific body on drugs. This week, we explore Drug Science’s newest observational study - Project Twenty21. We explore its aims to change the way medical cannabis is perceived and prescribed in the UK, it’s operati...

Where did modern cannabis research start? This week we’re honoured and privileged to be joined by the legendary Professor Raphael Mechoulam - heading up the Medical Chemistry department at the Hebrew University of Jerusalem. Dubbed ‘the godfather of cannabis research', Prof. Mechoulam has been a pioneer in the field, and over many decades has had a major influence on our understanding of the...

What is CBN? This week we’re joined by Alan Ridgeway, Co-Founder and CEO at FloraWorks - a Canadian hemp refinement laboratory offering specialised cannabinoid formulations. Together, we explore one of the 'minor' cannabinoids - CBN. We take a look at its incredible therapeutic properties, mechanism of action, and its potential as a market disruptor. → View full show notes and summary he...

This week we’re joined by Leah Fletcher, CEO and Founder of Arbutus Health Group - Irish GMP ready Pharmaceutical Group focusing on research and development. Together, we explore the benefits and applications of using cannabis topically, looking into how cosmetics are formulated, regulatory concerns, and the future use of CBD within cosmetics. About Leah Leah is the founder of Arbutus Innovation C...

How should we try and regulate medical cannabis in Europe? This week we’re joined by Benedikt and Jakob Sons, Co-founders of Cansativa - German GMP and GDP certified cannabis and pharmaceutical wholesalers.   Together, we take a detailed look into the current medical cannabis regulations in Germany, including the differences between federal and state governance, cannabis’ status as both a medical...

Why is standardisation so important for medical cannabis? This week we’re joined by Oliver Zugel, CEO and Founder of Foliumed - international producers of pharmaceutical grade cannabis, operating between Colombia and Germany. Together, we explore standardisation of cannabis as a medical product, including Good Manufacturing Practices (GMP), the challenges of standardising flower, and the market tr...

This week we’re joined by Tyler Robson, CEO at The Valens Company - biotech company and global leaders in the end-to-end production of cannabinoid-based products. Together, we discuss the newest wave of cannabis legalisation and innovation in Canada - Cannabis 2.0. We explore novel extraction techniques, the power of extracts and derivatives, the newest products on the market, and opportunities fo...